Visual Analogue ScaleAX-8RCC/UCCAX8throat discomfort
…plained chronic cough (RCC/UCC) and throat discomfort (baseline visual analogue scale [VAS] score ≥55 mm), the TRPM8 agonist AX-8 reduced bout freque…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 289 of 2459Visual Analogue ScaleLeicester Cough QuestionnairegefapixantNCT03449147refractory or unexplained chronic coughNCT03449134
…Diary; LCQ, Leicester Cough Questionnaire; OR, odds ratio; VAS, visual analog scale. a Estimated ORs based on logistic regression with the followin…
P156 Prevalence of cardiopulmonary events and risk factors before COPD diagnosis: ABACOS RISKS study
COPDCPRD Aurum
… individuals without COPD served as controls.Of 77,461 incident COPD cases (median age 68 years, 52% male, 93% White), 76.2% had at …
lung cancernon-small cell lung cancerstage IV diseaseNSCLCstage III-IV diseasebest supportive care
…population demographics within this cohort and for all stage IV lung cancer diagnoses between 2022 and 2024.Results Of 410 patients diagnos…
severe asthmamOCSPortsmouth Hospitals University NHS TrustBiologic therapiesPHU
…gic therapies confer substantial clinical benefit in real-world severe asthma, with high rates of symptom control, steroid reduction, and qua…
subglottic stenosisidiopathic SGSSGSBronchoscopic interventionGPAgranulomatosis with polyangiitis
…ronchoscopic interventions.Methods Retrospective analysis of 27 subglottic stenosis patients referred to adult respiratory service, in a large tert…
lung cancerlymphomasarcoidosisNSCLCSCLCmediastinal lymphadenopathyEBUS-TBNA
…BUS were performed with 3891 samples taken, including suspected lung cancer (n=2463), suspected metastatic disease (n=376), isolated medias…
COPDtracheobronchomalaciaECAC
…old and with FEV 1 ≥80% predicted, as part of the British Early COPD Network (BEACON) study. Morphological airway measurements were …
asthmaFeNOFeNO-testingFeNO-guidedmaintenance and reliever therapy
…as surprisingly high and did not align with their perception of asthma control and when significant changes in management, such as swi…
CyclophosphamidePR3-positive vasculitismethylprednisoloneCTD-ILDInterstitial lung disease (ILD)fibrotic NSIPprogressive sarcoidosisfibrotic organising pneumoniachronic hypersensitivity pneumonitisCYC+2 more
…of conditions that cause inflammation and fibrosis in the lung. Cyclophosphamide (CYC) is considered for patients with rapidly worsening ILD to …
chronic obstructive pulmonary diseasepulmonary rehabilitationCOPDPRtrain-the-trainer modelPR-buddy
…ary rehabilitation (PR). PR is the most effective treatment for chronic obstructive pulmonary disease (COPD), but its impact is limited by low uptake and completion.…